Matches in SemOpenAlex for { <https://semopenalex.org/work/W2947198732> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W2947198732 abstract "e14671 Background: The sensitivity of B-mode ultrasound (US) in detecting hepatic lesions has been reported to be between 55-85%. A recently FDA approved US contrast agent has been shown to increase the detectability of liver lesions; yet, there is paucity of knowledge regarding its application in US guided biopsies. The aim of this study was to determine accuracy and applicability of contrast enhanced US (CEUS) guided biopsies of liver lesions in cancer patients. Methods: A prospective registry of 75 patients (M = 54%, F = 46%, Age: 63y±14), that underwent CEUS guided liver biopsy in 2017-2018, were retrospectively reviewed. The decision to apply US contrast was made based on pre-procedural and intra-procedural clinical findings. Lesions with negative biopsy results were reviewed in follow up imaging to determine any evidence of potential positive malignancy. Results: History of renal failure that precluded application of iodinated IV contrast was the main pre-procedural indication (17%). Intra-procedural indications included: poor visualization of lesions in B-mode US (78%), targeting enhancing part of lesions (necrotic, post ablation or cystic) (16%), and lesion selection (6%). Diameter of the lesions were ≤ 20mm in 46% of patients. Biopsy results were positive in 50 patients, and included 32% primary liver tumors (hepatocellular carcinoma and cholangiocarcinoma) and 68% metastasis (pancreas: 24%, breast: 12%, GI tract: 10%, lung: 8% and other: 14%). Of the 25 patients with negative biopsy results, 6 did not have follow up imaging and 3 were later found to have positive malignancy (Negative predictive value: 84%, accuracy: 96%). Genomic sequencing was established in 34% of the patients. Based on the biopsy/genomics results, patients underwent systemic treatment (56%), locoregional treatment (16%), combination (6%) or surgery (2%). 10% of patients selected hospice care and 10% lost follow up. Conclusions: CEUS increases the accuracy of US guided biopsies of focal liver lesions, by improving visualization, targeting viable parts and also in patients with renal failure, or small lesions. Findings from these biopsies could improve management of cancer patients by categorizing them into different treatment groups." @default.
- W2947198732 created "2019-06-07" @default.
- W2947198732 creator A5000394894 @default.
- W2947198732 creator A5005056406 @default.
- W2947198732 creator A5010726715 @default.
- W2947198732 creator A5068417049 @default.
- W2947198732 creator A5070044404 @default.
- W2947198732 date "2019-05-20" @default.
- W2947198732 modified "2023-09-26" @default.
- W2947198732 title "Role of ultrasound contrast agent in a tertiary cancer center: Experience in 75 patients with liver biopsy." @default.
- W2947198732 doi "https://doi.org/10.1200/jco.2019.37.15_suppl.e14671" @default.
- W2947198732 hasPublicationYear "2019" @default.
- W2947198732 type Work @default.
- W2947198732 sameAs 2947198732 @default.
- W2947198732 citedByCount "0" @default.
- W2947198732 crossrefType "journal-article" @default.
- W2947198732 hasAuthorship W2947198732A5000394894 @default.
- W2947198732 hasAuthorship W2947198732A5005056406 @default.
- W2947198732 hasAuthorship W2947198732A5010726715 @default.
- W2947198732 hasAuthorship W2947198732A5068417049 @default.
- W2947198732 hasAuthorship W2947198732A5070044404 @default.
- W2947198732 hasConcept C121608353 @default.
- W2947198732 hasConcept C126322002 @default.
- W2947198732 hasConcept C126838900 @default.
- W2947198732 hasConcept C141071460 @default.
- W2947198732 hasConcept C143753070 @default.
- W2947198732 hasConcept C2775934546 @default.
- W2947198732 hasConcept C2776231280 @default.
- W2947198732 hasConcept C2777766500 @default.
- W2947198732 hasConcept C2779585989 @default.
- W2947198732 hasConcept C2991842025 @default.
- W2947198732 hasConcept C71924100 @default.
- W2947198732 hasConceptScore W2947198732C121608353 @default.
- W2947198732 hasConceptScore W2947198732C126322002 @default.
- W2947198732 hasConceptScore W2947198732C126838900 @default.
- W2947198732 hasConceptScore W2947198732C141071460 @default.
- W2947198732 hasConceptScore W2947198732C143753070 @default.
- W2947198732 hasConceptScore W2947198732C2775934546 @default.
- W2947198732 hasConceptScore W2947198732C2776231280 @default.
- W2947198732 hasConceptScore W2947198732C2777766500 @default.
- W2947198732 hasConceptScore W2947198732C2779585989 @default.
- W2947198732 hasConceptScore W2947198732C2991842025 @default.
- W2947198732 hasConceptScore W2947198732C71924100 @default.
- W2947198732 hasLocation W29471987321 @default.
- W2947198732 hasOpenAccess W2947198732 @default.
- W2947198732 hasPrimaryLocation W29471987321 @default.
- W2947198732 hasRelatedWork W1950933159 @default.
- W2947198732 hasRelatedWork W1986471304 @default.
- W2947198732 hasRelatedWork W1995821588 @default.
- W2947198732 hasRelatedWork W1998388982 @default.
- W2947198732 hasRelatedWork W2049116989 @default.
- W2947198732 hasRelatedWork W2058596123 @default.
- W2947198732 hasRelatedWork W2121428287 @default.
- W2947198732 hasRelatedWork W2133801956 @default.
- W2947198732 hasRelatedWork W2141180433 @default.
- W2947198732 hasRelatedWork W2174461294 @default.
- W2947198732 hasRelatedWork W2246321118 @default.
- W2947198732 hasRelatedWork W2370251005 @default.
- W2947198732 hasRelatedWork W2380156840 @default.
- W2947198732 hasRelatedWork W2414775926 @default.
- W2947198732 hasRelatedWork W2948640720 @default.
- W2947198732 hasRelatedWork W2960809986 @default.
- W2947198732 hasRelatedWork W3161890252 @default.
- W2947198732 hasRelatedWork W3207603382 @default.
- W2947198732 hasRelatedWork W59148547 @default.
- W2947198732 hasRelatedWork W97428805 @default.
- W2947198732 isParatext "false" @default.
- W2947198732 isRetracted "false" @default.
- W2947198732 magId "2947198732" @default.
- W2947198732 workType "article" @default.